News
The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...
In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...
Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...
Vinay Prasad, the U.S. Food and Drug Administration's top vaccine regulator, is returning to his post less than two weeks ...
A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results